ENTRY       D10023                      Drug
NAME        Pexelizumab (USAN/INN)
SEQUENCE    MDMRVPAQLL GLLLLWLRGA RCDIQMTQSP SSLSASVGDR VTITCGASEN IYGALNWYQR
            KPGKAPKLLI YGATNLADGV PSRFSGSGSG TDFTLTISSL QPEDFATYYC QNVLNTPLTF
            GQGTKVEIKR TGGGGSGGGG SGGGGSQVQL VQSGAEVKKP GASVKVSCKA SGYIFSNYWI
            QWVRQAPGQG LEWMGEILPG SGSTEYTENF KDRVTMTRDT STSTVYMELS SLRSEDTAVY
            YCARYFFGSS PNWYFDVWGQ GTLVTVSS
  TYPE      Peptide
EFFICACY    Anti-complement C5 antibody
  TYPE      Monoclonal antibody
COMMENT     Complement inhibitor used to reduce the impact of complement-mediated injuries sustained during cordiopulmonary bypass
TARGET      C5 [HSA:727] [KO:K03994]
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Complement and coagulation
                C5
                 D10023  Pexelizumab (USAN/INN)
DBLINKS     CAS: 219685-93-5
            PubChem: 135626744
///
